Grace Therapeutics, Inc. (GRCE)
Nasdaq: GRCE · CIK 0001444192 · United States
Every official Grace Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open GRCE filings
Grace Therapeutics, Inc. documents
- Grace Therapeutics, Inc. 10-K 2026GRCE 10-K 2026: annual report for fiscal 2026
- Grace Therapeutics, Inc. 10-K 2025GRCE 10-K 2025: annual report for fiscal 2025
- Grace Therapeutics, Inc. 10-K 2024GRCE 10-K 2024: annual report for fiscal 2024
- Grace Therapeutics, Inc. 10-K 2023GRCE 10-K 2023: annual report for fiscal 2023
- Grace Therapeutics, Inc. 10-K 2022GRCE 10-K 2022: annual report for fiscal 2022
- Grace Therapeutics, Inc. 10-Q 2026GRCE 10-Q 2026: quarterly report for fiscal 2026
- Grace Therapeutics, Inc. 10-Q 2025GRCE 10-Q 2025: quarterly report for fiscal 2025
- Grace Therapeutics, Inc. 10-Q 2024GRCE 10-Q 2024: quarterly report for fiscal 2024
- Grace Therapeutics, Inc. 10-Q 2023GRCE 10-Q 2023: quarterly report for fiscal 2023
- Grace Therapeutics, Inc. 10-Q 2022GRCE 10-Q 2022: quarterly report for fiscal 2022
- Grace Therapeutics, Inc. 8-K 2026GRCE 8-K 2026: current report for fiscal 2026
- Grace Therapeutics, Inc. 8-K 2025GRCE 8-K 2025: current report for fiscal 2025
- Grace Therapeutics, Inc. 8-K 2024GRCE 8-K 2024: current report for fiscal 2024
- Grace Therapeutics, Inc. 8-K 2023GRCE 8-K 2023: current report for fiscal 2023
- Grace Therapeutics, Inc. 8-K 2022GRCE 8-K 2022: current report for fiscal 2022
- Grace Therapeutics, Inc. DEF 14A 2026GRCE DEF 14A 2026: proxy statement for fiscal 2026
- Grace Therapeutics, Inc. DEF 14A 2025GRCE DEF 14A 2025: proxy statement for fiscal 2025
- Grace Therapeutics, Inc. DEF 14A 2024GRCE DEF 14A 2024: proxy statement for fiscal 2024
- Grace Therapeutics, Inc. DEF 14A 2023GRCE DEF 14A 2023: proxy statement for fiscal 2023
- Grace Therapeutics, Inc. DEF 14A 2022GRCE DEF 14A 2022: proxy statement for fiscal 2022
- Grace Therapeutics, Inc. Form 4 2026GRCE Form 4 2026: insider trading filing for fiscal 2026
- Grace Therapeutics, Inc. Form 4 2025GRCE Form 4 2025: insider trading filing for fiscal 2025
- Grace Therapeutics, Inc. Form 4 2024GRCE Form 4 2024: insider trading filing for fiscal 2024
- Grace Therapeutics, Inc. Form 4 2023GRCE Form 4 2023: insider trading filing for fiscal 2023
- Grace Therapeutics, Inc. Form 4 2022GRCE Form 4 2022: insider trading filing for fiscal 2022
- Grace Therapeutics, Inc. S-1 2026GRCE S-1 2026: registration statement for fiscal 2026
- Grace Therapeutics, Inc. S-1 2025GRCE S-1 2025: registration statement for fiscal 2025
- Grace Therapeutics, Inc. S-1 2024GRCE S-1 2024: registration statement for fiscal 2024
- Grace Therapeutics, Inc. S-1 2023GRCE S-1 2023: registration statement for fiscal 2023
- Grace Therapeutics, Inc. S-1 2022GRCE S-1 2022: registration statement for fiscal 2022
- Grace Therapeutics, Inc. 13F 2026GRCE 13F 2026: institutional holdings for fiscal 2026
- Grace Therapeutics, Inc. 13F 2025GRCE 13F 2025: institutional holdings for fiscal 2025
- Grace Therapeutics, Inc. 13F 2024GRCE 13F 2024: institutional holdings for fiscal 2024
- Grace Therapeutics, Inc. 13F 2023GRCE 13F 2023: institutional holdings for fiscal 2023
- Grace Therapeutics, Inc. 13F 2022GRCE 13F 2022: institutional holdings for fiscal 2022
More companies